Evaluating closed-loop treatment for atrial fibrillation
Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community
This study tests a new treatment method for people with atrial fibrillation to see if it can improve their care and health outcomes after undergoing a specific heart procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Shanghai 10th People's Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT05311137 on ClinicalTrials.gov |
What this trial studies
This study evaluates a closed-loop treatment approach for patients with atrial fibrillation, focusing on optimizing treatment strategies and improving disease outcomes. It aims to enhance patient understanding of atrial fibrillation and assess the economic implications of this treatment concept within the northern Shanghai community. The study involves monitoring patients who undergo radiofrequency ablation as part of their treatment plan.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with atrial fibrillation who can understand and sign informed consent.
Not a fit: Patients who do not have atrial fibrillation or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved management and outcomes for patients with atrial fibrillation.
How similar studies have performed: While the concept of closed-loop treatment is innovative, similar approaches in managing atrial fibrillation have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * atrial fibrillation patients；Ability to act autonomously, understand and sign informed consent； Exclusion Criteria: * none（All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up）
Where this trial is running
Shanghai, Shanghai Municipality
- Shanghai Tenth People's Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: DongDong Zhao, PhD
- Email: zhaodd@tongji.edu.cn
- Phone: +86 18917684008
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.